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I I I  
Abstract 
In this thesis, we focused on imaging of the primary hepatocellular 
carcinoma with glycosylated micelles in a rat model. This thesis consists of three 
sections. 
The first part aimed to modified the diethylnitrosamine (DEN) induced the 
primary rat model of liver cancer. Hepatocellular carcinoma (HCC) is the fifth high 
incidence cancer in the world. There are 13 million new cases every year and 7.6 
million cases of death, about 55% of the new liver cancer patients so that HCC 
becomes the second fatal tumor in China. About more than 80% o f the 
hepatocellular carcinoma under the background of liver cirrhotic. Hepatitis，liver 
fibrosis，cirrhosis of the liver were regarded as the common development process. 
The tumor microenvironment and pathological conditions of animal xenograft tumor 
models employed for surgerical evaluation are significantly different from the 
primary hepatocellular carcinoma models. As such, diethylnitrosamine 
(DEN)-induced primary hepatocellular carcinoma models are superior to evaluate 
the efficacy of tumor targeting drugs as comapred to xenograft tumor models. Herein 
we report the development of an improved DEN-induced tumor method in mice with 
100% cancer rate and zero mortality. 
The second part mainly introduces the imaging of the primary hepatocellular 
carcinoma with a kind of acid sensitive rhodamine functional glycosylated 
fluorescence micelles in rats model. Much eﬀort has been devoted to the use of 
glycan-bearing vectors for delivery of therapeutics by targeting cell surface lectins 
such as ASPGR, mannose receptors, Siglecs, etc. In contrast, there is a lack of eﬀort 
on the use of glyco-probes for fluorescence-guided tumor detection. Recently an 
article reported a kind of acid sensitive rhodamine functionalization of the 
poly(styrene-maleic acid) (RST@P) fluorescence maerial, its key according to liver 















receptor (RST@P-Gal), mannose receptor (RST@P-Man) for different levels of 
tumor imaging fluorescence detection, is grown in the subcutaneous tumor model 
and in situ liver tumor model showed higher tumor targeting with low background 
signals. But the development of tumor and its internal environment, it is made up of 
tumor cells, mesenchymal cells and capillaries, tissue fluid, and a small amount of 
infiltrating cells to form, is different from the normal cells and its formed by the 
surrounding tissue microenvironment, they interact with the tumor, the cells become 
cancerous, the transfer of cancer cells, and the interference resistance and target of 
anticancer drugs, etc all have important role. Subcutaneous tumor model and in situ 
liver tumors grow model cannot very good mimic the natural state of tumor cell 
micro environment, to evaluate the target of the fluorescent material, etc, some 
deficiencies. And primary rat model of liver cancer to evaluate the real clinical 
application value of fluorescence materials have important significance. 
 

















HCC：hepatocellular carcinoma，肝细胞癌  





AML：acute myeloblastic leukemia，急性粒细胞白血病 
NCI：National Cancer Institute，美国国家癌病学会  
HBeAg：Hepatitis B e Antigen，乙型肝炎病毒 E 抗原 
HBV：Hepatitis B Virus，乙型肝炎病毒 
AFP：α-fetoprotein，甲胎蛋白 
ALB：Albumin，白蛋白 




















第一章 前 言 
1.  动物肝癌模型 
1.1  动物肝癌模型背景   
肝细胞癌(hepatocellular carcinoma, HCC；以下简称肝癌)发病率高居世界第
五的高致死率恶性肿瘤之一。近年来肝癌的病死率呈上升趋势，全球每年新发 
















































性大鼠肝癌模型。有研究曾采用 Walker-256 瘤株(来源于 AFP 阴性的大鼠自发
性乳腺癌，具有一定的肉瘤性质)，通过不同方法移植人大鼠的肝脏，从而形成






























要求高。   











































2.  肿瘤靶向性荧光纳米材料 
2.1  肝脏肿瘤诊治现状 
肝癌是全球第五大高发癌症，也是世界范围内死亡率最高的恶性肿瘤之一。




低（约 25%），5 年生存率徘徊在 38%～47%，术后的复发率高达 61.5%，这些
可能与肝癌早期诊断率低，术前、术中未能发现微小（直径小于 5 mm）肝癌病
灶有关[20-24]。 
















































图 1 荧光探针在肺癌小鼠内成像[27] 
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图 2 荧光探针帮助外科医生发现微小肿瘤[28] 
Figure 2. Fluorescent probe to help surgeons found small tumors[28] 
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